Committed to Regenerating Your Cells for Life
Moraga Biotechnology Corporation is an adult stem cell-based company headquartered in Los Angeles, California. The Company was formed in September 2004, with the scientific founders who have over thirty years of experience in adult stem cell research.
Moraga Biotech has discovered and isolated a very primitive population of stem cells from adult tissues. Moraga has also purified, propagated, and cloned these stem cells with our proprietary serum-free defined media. These adult stem cells have unique properties that resemble cells found during very early embryonic development, which surprisingly are retained in adult tissues. Because of their ability to differentiate into most, if not all tissues and organs of the body, these adult stem cells exhibit totipotent properties and are therefore referred to as Blastomere-Like Stem Cells (BLSCs). The photograph to the right depicts a cluster of ELSCs (larger cells, arrowheads) and BLSCs (smaller cells, arrows) growing on top of a layer of germ layer lineage stem cells.
With Moraga's new proprietary process, millions of BLSCs can be isolated from fresh adult tissues without ex vivo expansion. The Company intends to use its BLSCs in a high-throughput drug discovery platform, particularly for targeted anti-cancer therapies, as well as in cell-based therapeutic applications for regenerating normal functional tissues that have been damaged either by an acute injury or by various disease processes.
Moraga's strategic plan is to develop core competencies and business units in the following areas:
- Selling both our stem cells and serum-free defined culture media as reagents to the life science research markets.
- Using our stem cells in high content and high-throughput screening platforms for discovering novel biological factors and drug targets.
- Banking of adult stem cells and differentiated tissue(s) of individuals in order to bridge the gap towards personalized medicine.
- Providing a platform for cell-based therapies in order to restore normal tissue function in the field of regenerative medicine.
- Using the BLSCs to find novel molecular pathways in a discovery platform dedicated to developing targeted anti-cancer therapies.